Table 1.
PROMOTE Participant Characteristics, Overall and by Study (N = 201)
| Arms | |||||
|---|---|---|---|---|---|
| Variables | Total (N = 201) | Comparison (n = 67) | Summary (n = 67) | Control (n = 67) | P value* |
| Median Age (IQR) | 70 (62, 73) | 70 (61, 75) | 70 (63, 73) | 69 (61, 73) | 0.71 (K) |
| Mean Age (SD) | 67 (10) | 68 (10) | 67 (11) | 67 (10) | |
| Male (%) | 114 (57) | 42 (63) | 33 (49) | 39 (58) | 0.28 (P) |
| Median BMI (IQR) | 30 (27, 36) | 31 (29, 36) | 30 (26, 35) | 31 (27, 36) | 0.14 (K) |
| Race (%) | 0.35 (P) | ||||
| American Indian | 1 (1) | 1 (1) | 0 | 0 | |
| Asian | 5 (2) | 1 (1) | 3 (4) | 1 (1) | |
| Black | 18 (9) | 8 (12) | 8 (12) | 2 (3) | |
| Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | |
| White | 173 (86) | 56 (84) | 54 (81) | 63 (94) | |
| Other/Multiracial | 4 (2) | 1 (1) | 2 (3) | 1 (1) | |
| Hispanic ethnicity | 8 (4) | 4 (6) | 2 (3) | 2 (3) | 0.59 (P) |
| Insurance type ** | 0.05 (P) | ||||
| Private | 34 (17) | 4 (6) | 16 (24) | 14 (21) | |
| Medicare | 161 (80) | 59 (88) | 50 (75) | 52 (78) | |
| Medicaid | 4 (2) | 3 (4) | 0 | 1 (1) | |
| Self-Insured | 1 (1) | 0 | 1 (1) | 0 | |
| Uninsured | 1 (1) | 1 (1) | 0 | 0 | |
| Frequently fill statin medication without using Humana | 33 (16) | 13 (19) | 12 (18) | 8 (12) | 0.47 (P) |
| Diabetes type | 0.53 (P) | ||||
| Type 1 | 12 (6) | 4 (6) | 4 (6) | 4 (6) | |
| Type 2 | 182 (91) | 62 (93) | 62 (93) | 58 (88) | |
| Other/Unknown | 6 (3) | 1(1) | 1(1) | 4 (6) | |
| Missing | 1 | 0 | 0 | 1 | |
| Highest level of education | 0.984 (P) | ||||
| Less than High School | 10 (5) | 3 (4) | 3 (5) | 4 (6) | |
| GED | 9 (4) | 4 (6) | 3 (4) | 2 (3) | |
| High School Degree | 41 (20) | 13 (19) | 13 (19) | 15 (22) | |
| Some College | 61 (30) | 18 (27) | 24 (36) | 19 (28) | |
| Collage Degree | 47 (23) | 18 (27) | 13 (19) | 16 (24) | |
| Graduate Degree | 33 (16) | 11 (16) | 11 (16) | 11 (16) | |
| Median Morisky Score (IQR) | 6 (4.75, 7) | 6 (5, 7) | 6 (4.75, 7) | 5.5 (4.75, 7) | 0.097 (K) |
| Categorical Morisky Score | 0.06 (P) | ||||
| High Adherence | 3 (2) | 1 (2) | 1 (2) | 1 (1) | |
| Medium Adherence | 100 (50) | 36 (55) | 40 (61) | 24 (36) | |
| Low Adherence | 96 (48) | 29 (44) | 25 (38) | 42 (63) | |
| Missing | 2 | 1 | 1 | 0 | |
| Median Baseline MPR (IQR) | 0.58 (0.49, 0.74) | 0.66 (0.49, 0.74) | 0.49 (0.33, 0.74) | 0.58 (0.49, 0.74) | 0.33 (K) |
| Median Number of Meds (IQR) | 10 (6, 13) | 9 (7, 12) | 10 (6, 13) | 10 (6, 15.5) | 0.89 (K) |
* K = Kruskal–Wallis test, P = Pearson's Chi-Square Test
** This category indicates the primary payer, although all participants had their health benefits provided through Humana. For example, Medicare beneficiaries in the study had Medicare Advantage plans that were provided through Humana. As a second example, some patients had Medicaid which had contracted with Humana to provide insurance benefits